AMGN vs JD · P/E 24, rev $10.05B vs P/E 7.6, rev $187.20B
Amgen Inc (AMGN) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the AMGN and JD stock pages for the full models.
Not investment advice.